Receptor Occupancy

Receptor Occupancy describes the proportion of a target receptor population bound by a drug at a given concentration, providing a mechanistic link between pharmacokinetics, target engagement, and pharmacodynamic response. This concept underpins receptor theory and helps explain why increasing dose may produce greater effects up to a saturation point where most receptors are occupied.

The biopharmaceutical industry uses receptor occupancy measurements to guide dose selection, establish proof of mechanism, and reduce late-stage clinical failure by confirming that drugs reach and engage their intended targets in humans. In central nervous system development, positron emission tomography (PET) imaging with radiolabelled ligands enables direct measurement of receptor occupancy in the brain, supporting translation from preclinical models. In oncology and immunology, receptor occupancy can inform whether a monoclonal antibody achieves adequate target coverage in tumours or immune compartments, guiding dosing frequency and regimen design. Challenges include heterogeneity of receptor expression across tissues, dynamic receptor turnover, and differences between circulating and tissue compartments. As model-informed drug development becomes increasingly standard, receptor occupancy remains a powerful framework for integrating pharmacology, clinical strategy, and mechanistic confidence into rational dosing decisions.